Corundum Trust Company’s Oracle ORCL Stock Holding History

Corundum Trust Company’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-137	Closed	-$38.5K	–	97
2025 Q3	$38.5K	Buy	+137	New	+$34.9K	0.08%	86

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Corundum Trust Company's ORCL Position: Q4 2025 in Review

Corundum Trust Company sold out of Oracle (ORCL) in Q4 2025, closing a stake of 137 shares — an estimated $38.5K sold.

Corundum Trust Company first reported a position in ORCL in Q3 2025 and held it in 1 quarter. The position peaked at $38.5K in Q3 2025. 3,764 funds tracked by Wall St. Rank hold ORCL as of Q4 2025.

Corundum Trust Company reported no remaining Oracle position as of Q4 2025 after selling out during the quarter.
Corundum Trust Company sold 137 Oracle shares in Q4 2025, an estimated $38.5K.
Corundum Trust Company first reported a position in Oracle in Q3 2025 and held it in 1 quarter.
Corundum Trust Company's Oracle position peaked at $38.5K in Q3 2025.
3,764 funds tracked by Wall St. Rank held Oracle as of Q4 2025.

Based on Corundum Trust Company's 13F filing for Q4 2025, filed 20 Jan 2026.